Risk factor
Very high price volatility
Profitability factor
Greatly undervalued vs peers
About
Tilray Brands, Inc. operates as a consumer lifestyle company primarily involved in the research, cultivation, manufacturing, and worldwide supply of medical cannabis products. Its expansive global footprint includes Canada, the United States, Europe, the Middle East, Africa, and numerous other international regions. The company's business activities are organized into four distinct segments: Beverages, Cannabis, Distribution, and Wellness. Beyond its medical cannabis offerings, Tilray Brands also provides products for adult recreational cannabis markets. The company further diversifies its portfolio by reselling and distributing pharmaceutical and wellness items, as well as producing, marketing, and selling a range of beverage and hemp-derived food products. Its offerings also extend to entertainment products. These varied products are marketed under a vast collection of brand names, featuring prominent labels such as Tilray, Aphria, Broken Coast, SweetWater Brewing, and HEXO, among many others. Tilray Brands utilizes a broad distribution network, selling its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, governments, and directly to consumers. The company, which was formerly known as Tilray, Inc., officially adopted the name Tilray Brands, Inc. in January 2022. Its corporate headquarters are situated in Leamington, Canada.
Company Valuation
From both historical and forecast perspectives, the stock is considerably underpriced compared to similar stocks.
Target Price
The average target price of TLRY is 9.8 and suggests 93% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to increas